Stay organized with My Personal Journal
When you're living with multiple sclerosis (MS), it's helpful to have a single place to keep all your MS treatment-related information organized. that's why we created the My Personal Journal.
Your My Personal Journal offers:
- A place to list all your important information: phone and fax numbers, addresses, e-mail addresses, contact names, insurance policy numbers, and your current medications
- Monthly calendars and injection maps for planning and tracking your BETASERON injections
- Quarterly treatment trackers to help you stay on top of your BETASERON therapy and write down questions to ask your healthcare team
- A place to record your medical appointments and any notes from the visits
- Answers to commonly asked questions about using and traveling with BETASERON
INDICATIONS AND USAGE
BETASERON® (interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.
IMPORTANT SAFETY INFORMATION
- BETASERON should be used with caution in patients with depression.
- Injection-site necrosis has been reported in 4% of patients in controlled trials. Patients should be advised of the importance of rotating injection sites.
- Severe hepatic injury, including cases of hepatic failure, has been reported. Patients should be monitored for liver enzyme elevations while taking BETASERON.
- BETASERON should be used with caution in patients with seizure disorders or cardiac disease.
- Female patients should be warned about the potential risk to pregnancy.
- Cases of anaphylaxis have been reported rarely.
- The most commonly reported adverse reactions are lymphopenia (low numbers of a certain kind of white blood cell), Injection-site reaction, asthenia (general weakness), flu-like symptom complex (flu syndrome and/or a combination of at least two Adverse Events from fever, chills, muscle aches, tiredness and sweating), headache and pain. Gradual dose titration and use of analgesics during treatment initiation may help reduce flu-like symptoms.
See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information.
For important risk and use information, please see the full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
